Levita Hidayat
- Infectious Diseases top 2%
- Clinical Biochemistry top 0.5%
- Pharmacology top 5%
- Epidemiology
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Donald HsuRyan QuistAnnie Wong‐BeringerKimberly ShrinerJanet HindlerÅsa KarlssonMichael BolarisJason Yamaki
- Topics
- Antibiotic Use and Resistance (9 papers)Bacterial Identification and Susceptibility Testing (8 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)
- Journals
- Journal of Antimicrobial ChemotherapyInternational Journal of Antimicrobial AgentsThe Journal of Clinical Pharmacology
- Partner nations
- United StatesSweden
In The Last Decade
Levita Hidayat
18 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Infectious Diseases 737
- Clinical Biochemistry 575
- Pharmacology 302
- Epidemiology 245
- Public Health, Environmental and Occupational Health 190
Countries citing papers authored by Levita Hidayat
This map shows the geographic impact of Levita Hidayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levita Hidayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levita Hidayat more than expected).
Fields of papers citing papers by Levita Hidayat
This network shows the impact of papers produced by Levita Hidayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levita Hidayat. The network helps show where Levita Hidayat may publish in the future.
Co-authorship network of co-authors of Levita Hidayat
This figure shows the co-authorship network connecting the top 25 collaborators of Levita Hidayat. A scholar is included among the top collaborators of Levita Hidayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levita Hidayat. Levita Hidayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 60 | |
| 4 | 46 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 3 | |
| 8 | 24 | |
| 9 | 11 | |
| 10 | 9 | |
| 11 | Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States | 4 |
| 12 | 28 | |
| 13 | 50 | |
| 14 | 32 | |
| 15 | 16 | |
| 16 | 22 | |
| 17 | 144 | |
| 18 | High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infectionsbreakdown → | 691 |
About Levita Hidayat
Levita Hidayat is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Geriatrics and Gerontology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Clinical Biochemistry (575 citations), Applied Microbiology and Biotechnology (154 citations) and Infectious Diseases (737 citations). Levita Hidayat has collaborated with scholars based in United States and Sweden. Frequent co-authors include Donald Hsu, Ryan Quist, Annie Wong‐Beringer, Kimberly Shriner, Janet Hindler, Åsa Karlsson, Michael Bolaris, Jason Yamaki, Esther Kim and C Andrew DeRyke. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.